Wave Life Sciences (WVE) Long-Term Deferred Tax (2014 - 2017)

Wave Life Sciences' Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $774000.0 for Q2 2017.

• Quarterly Long-Term Deferred Tax rose 303.12% year-over-year to $774000.0 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $774000.0 (up 303.12% YoY) and the FY2016 annual result came in at $560000.0, up 191.67% from the prior year.
• Long-Term Deferred Tax was $774000.0 for Q2 2017 at Wave Life Sciences, roughly flat from $774000.0 in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $774000.0 in Q1 2017 and bottomed at $32000.0 in Q3 2016.
• A 4-year average of $362250.0 and a median of $192000.0 in 2015 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2015 — Long-Term Deferred Tax gained 5.49% — and 2017, when it surged 303.12%.
• Wave Life Sciences' Long-Term Deferred Tax stood at $182000.0 in 2014, then increased by 5.49% to $192000.0 in 2015, then jumped by 191.67% to $560000.0 in 2016, then jumped by 38.21% to $774000.0 in 2017.
• Business Quant data shows WVE's Long-Term Deferred Tax at $774000.0 in Q2 2017, $774000.0 in Q1 2017, and $560000.0 in Q4 2016.